Principal Healthcare Innovators ETF is a ETF series of Principal Exchange-Traded Funds (series S000054611). Net assets $16.4M as of 2024-06-30.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc | — | $855K | 519.76% |
| Moderna Inc | — | $588K | 357.85% |
| Sarepta Therapeutics Inc | — | $525K | 319.02% |
| Natera Inc | — | $464K | 281.94% |
| Illumina Inc | — | $401K | 244.15% |
| Catalent Inc | — | $361K | 219.31% |
| Insmed Inc | — | $358K | 217.71% |
| Roivant Sciences Ltd | — | $303K | 184.42% |
| Vaxcyte Inc | — | $290K | 176.16% |
| Exact Sciences Corp | — | $272K | 165.27% |
| Cerevel Therapeutics Holdings Inc | — | $263K | 159.70% |
| Elanco Animal Health Inc | — | $253K | 154.13% |
| Ionis Pharmaceuticals Inc | — | $247K | 150.09% |
| Blueprint Medicines Corp | — | $237K | 143.94% |
| Intra-Cellular Therapies Inc | — | $235K | 142.95% |
| Report date | Net assets |
|---|---|
| 2024-06-30 | $16.4M |
| 2024-03-31 | $44.6M |
| 2023-12-31 | $49.1M |
| 2023-09-30 | $45.1M |
| 2023-06-30 | $54.0M |
| 2023-03-31 | $51.5M |
| 2022-12-31 | $55.6M |
| 2022-09-30 | $58.4M |